Singapore: UK Animal health company Zoetis has announced that its joint venture in China has received regulatory approva...
Singapore: After 60 comeback cases of Polio this year, Pakistan has ultimately taken a step to eradicate the crippling d...
Singapore: Medicago executed a $15 million loan agreement with a major pharmaceutical company. The principal of the loan...
Singapore: US-based vaccine development company Medicago demonstrated that a single, non-adjuvanted, intramuscular dose ...
Singapore: The Developing Countries Vaccine Manufacturers Network (DCVMN) has lauded the initiatives and cooperation of...
Singapore: Astellas Pharma has launched the combined vaccine for the prevention of pertussis, diphtheria, tetanus, and p...
India, which was once considered as the world's epicenter of polio, successfully interrupted the transmission of the wil...
Singapore: Sanofi Pasteur, the vaccines division of Sanofi, has launched IMOJEV vaccine against Japanese encephalitis (J...
Singapore: Australian biopharmaceutical company Imugene has appointed Dr Christoph Zielinski and Dr Ursula Wiedermann to...
Singapore: Researchers at nine sites have begun testing in humans an investigational H7N9 avian influenza vaccine. The t...
Singapore: In a bid to curtail the growing cases of influenza in Japan, Astellas announced that it has submitted an app...
Singapore: Researchers at the Institute for Cell Dynamics and Biotech at Universidad de Chile are developing a new vacci...
Singapore: Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers a...
Singapore: WHO along with European Respiratory Society (ERS), has outlined a framework to work on pre-elimination of tub...
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...
Singapore: Germany's Riboxx Pharmaceuticals and China National Biotec Group (CNBG) have initiated a research collaborati...
Singapore: Roche and Inovio Pharmaceuticals entered into an exclusive worldwide license agreement to R&D and commerc...
Singapore: Australian vaccine development company BioDiem announced that it has begun research collaboration with France...
